Tag Archives: Cuts
The Pain in Spain
The pain of the Spanish drug-spending squeeze extends way beyond the plain, says Reflector.
The cries of anguish at Spanish drug-spending squeezes are coming not only from Madrid, but from many of the autonomous regions around the periphery of the country too.
After almost a decade of continual disruption and downward pressure on pricing, the medicines industry [...]
Posted in Europe, Global, Guest Blog, Regulatory Also tagged generics, reference pricing, Spain 2 Comments
2010: A Year of Big Layoffs for Big Pharma
What are the factors that are contributing to the layoffs that have taken place at virtually all the Big Pharma companies this year?
According to the newly released Job-Cut Announcement Report from outplacement consultancy firm Challenger, Gray & Christmas, pharma has cut more than 6,000 jobs in September alone, and more than 43,000 so far this [...]
Judgment Day for Pfizer Factories
For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015.
In 2006, the company announced plans to save $4 billion to $5 billion, and after [...]
Posted in Europe, Global, Manufacturing, News, Strategy Also tagged exit strategies, injectables, Ireland, Manufacturing, Pfizer, solid-dose Leave a comment

Warner-Chilcott's Cuts in Europe — Good News for US?